Pharmaceutical Quality Control Release Testing Service Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, March 5, 2026 /EINPresswire.com/ — The pharmaceutical quality control release testing service market has been experiencing significant growth, driven by evolving industry needs and technological advancements. This sector plays a critical role in ensuring the safety and efficacy of pharmaceutical products, and its expansion reflects broader trends in drug development and regulatory compliance. Below is an overview of the market size, key drivers, regional insights, and future outlook.
Pharmaceutical Quality Control Release Testing Service Market Size and Expected Growth
In recent years, the pharmaceutical quality control release testing service market has seen robust development. It is projected to grow from $7.55 billion in 2025 to $8.13 billion in 2026, registering a compound annual growth rate (CAGR) of 7.6%. This past growth has been largely fueled by stricter good manufacturing practice (GMP) regulations, increasing global drug production, the rise of contract testing laboratories, expanding biologics testing demands, and growth in generic drug manufacturing.
Download a free sample of the pharmaceutical quality control release testing service market report:
Looking ahead, the market is set for continued strong expansion. By 2030, it is expected to reach $11.01 billion, with a CAGR of 7.9% from 2026 to 2030. Key factors supporting this forecast include the development of complex biologic pipelines, more frequent regulatory audits, broader adoption of outsourced quality control models, a stronger need for accelerated batch release cycles, and a rise in multi-region drug approvals. Emerging trends shaping the future market landscape include automated batch release testing, implementation of digital quality management systems, AI-driven analytical validation, connected stability testing laboratories, and intelligent quality data platforms.
Understanding Pharmaceutical Quality Control Release Testing Services
Pharmaceutical quality control release testing services are essential in verifying that pharmaceutical products comply with established quality, safety, and regulatory criteria before they enter the market. These services involve detailed testing and examination of raw materials, in-process samples, and final drug products to confirm their identity, potency, purity, strength, and adherence to applicable standards. They provide support to manufacturers by safeguarding product integrity, protecting patient safety, and ensuring compliance with stringent global regulations throughout complex drug production processes.
View the full pharmaceutical quality control release testing service market report:
Growth Catalyst: Expansion of Cell and Gene Therapy Pipelines
A major driver of growth in the pharmaceutical quality control release testing service market is the rapid expansion of cell and gene therapy pipelines. These pipelines consist of advanced cellular and genetic therapies currently in development or under regulatory review for commercialization. Investment in biotechnology research and development is escalating, with pharmaceutical companies and biotech firms dedicating significant resources to innovative therapies targeting diseases that were previously untreatable. The growing number of cell and gene therapy programs directly boosts demand for specialized quality control release testing to confirm that these sophisticated biological products meet rigorous safety and efficacy standards prior to market release. For example, in January 2025, the American Society of Gene and Cell Therapy reported that the global gene therapy pipeline increased to 2,117 programs in the fourth quarter of 2024, up from 2,041 programs in the previous quarter. This trend clearly illustrates how the expansion in cell and gene therapy pipelines is propelling market growth.
Regional Insights on Market Share and Growth Dynamics
In 2025, North America held the largest share of the pharmaceutical quality control release testing service market, reflecting the region’s strong pharmaceutical infrastructure and regulatory environment. Meanwhile, Asia-Pacific is expected to emerge as the fastest-growing region over the forecast period, driven by expanding pharmaceutical manufacturing, increasing regulatory harmonization, and rising investment in biotech and generics production. The market report covers various regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on market trends and growth opportunities.
Browse Through More Reports Similar to the Global Pharmaceutical Quality Control Release Testing Service Market 2026, By The Business Research Company
pharma ADMET testing global market report
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report
pharmaceutical label global market report
https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report
Pharmaceuticals Market
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: [email protected]
The Business Research Company – https://www.thebusinessresearchcompany.com/?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=home_page_test
Follow Us On:
* LinkedIn: https://in.linkedin.com/company/the-business-research-company”
Oliver Guirdham
The Business Research Company
+44 7882 955267
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
